Early trials of a breakthrough stem cell therapy to treat babies with spina bifida while still in the womb is showing remarkable results. The trial results published today in The Lancet medical ...
A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...
In-utero treatment of myelomeningocele, the most severe form of spina bifida, with allogeneic, live stem cells was feasible and safe, a first in-human, phase I, single-arm study i ...
Early trials of a breakthrough stem cell therapy to treat babies with spina bifida while still in the womb is showing remarkable results. The trial results published today in The Lancet medical ...
A Phase I clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery ...
A phase 1 clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery before birth is a safe and ...
Experimental therapy of applying stem cells during surgery could be ‘major milestone’ in treatment of birth defects ...
Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with ...
Childbirth doesnt end with the babys arrival A gynaecologist explains the final stage of labour the delivery of the placenta ...
Some calving cows and heifers may just need more time to go through the different stages of labour, rather than have ...
As the number of cesarean sections has increased over the past 30 years, a faster surgical closure technique has gained widespread use but may increase long-term complications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results